AI GRAND ROUNDS

Authors: GEMINI (RESIDENT), GROK (ATTENDING), KIMI (EXPERT) & ANUPAM SINGH MD (Human in loop)

Department of Medicine, Santosh Medical College.

Click here for App | Agentic Grand Rounds Index

User:

Resident: Attending: Expert: User: Stage 1: History & Presentation (Timestamp: 18 Months Prior to Admission)
A 57-year-old woman (residing in Delhi NCR, past surgical history of Roux-en-Y gastric bypass 4 years prior, edentulous, chronic back pain) presents with an 18-month history of progressive numbness, paresthesias, and severe motor weakness in both legs and arms.
HPI:
- 18 Months Ago: Onset of numbness in feet. Underwent L3-L4 lumbar laminectomy for suspected radiculopathy with minimal relief.
- 9 Months Ago: Recurrence and rostral progression of numbness and weakness extending to legs and hands. Developed frequent falls, requiring a cane and then a wheelchair.
- 8 Months Ago: Evaluated at an outpatient clinic; presumptive diagnosis of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) was made. Treated with monthly Intravenous Immunoglobulin (IVIG) for 6 months without sustained improvement.
- Presenting Complaint: Unable to transfer into a wheelchair, loss of bowel/bladder control, and diffuse numbness reaching the upper chest.

Resident:

Hello, Chief Resident here.

Key Findings:
A 57-year-old edentulous woman, 4 years post-Roux-en-Y gastric bypass (RYGB), presenting with a severe, progressive subacute myeloneuropathy (quadriparesis, chest sensory level, loss of bowel/bladder control) refractory to lumbar surgery and IVIG. Malabsorption secondary to bariatric surgery is a critical context.

Differential Diagnoses:
1. Copper Deficiency Myelopathy (45%): Highly characteristic post-RYGB malabsorptive neurological presentation mimicking Subacute Combined Degeneration (SCD).
2. Vitamin B12 Deficiency / SCD (30%): Classic post-bariatric complication presenting with dorsal/lateral column dysfunction and peripheral neuropathy.
3. Cervical Spondylotic Myelopathy (15%): Mechanical cord compression given progressive motor weakness, upper chest level, and history of spine disease.
4. Autoimmune Myelopathy / Chronic Demyelinating Disease (10%): Includes NMOSD/MOGAD or refractory atypical CIDP/overlap, though non-response to IVIG lowers probability.

Recommended Prioritized Tests:
1. Serum Copper, Ceruloplasmin, and Zinc levels.
2. Serum Vitamin B12, Methylmalonic Acid (MMA), and Homocysteine.
3. Contrast-enhanced MRI of Cervical and Thoracic Spine (to evaluate cord signal changes or structural compression).
4. Nerve Conduction Velocity (NCV) / Electromyography (EMG) (to characterize peripheral vs. central disease).

Attending:

Hello Attending Consultant here

Critique: Solid prioritization of post-bariatric malabsorption, but overweights CIDP mimicry; fails to urgently exclude compressive myelopathy before empiric labs. EMG/NCV premature without imaging. Zinc co-testing essential (induces copper deficiency).

Top 3 DDx:
1. Copper deficiency myeloneuropathy (post-RYGB)
2. B12 deficiency/SCD
3. Cervical spondylotic myelopathy ± cord compression

Specific points:
1. Stat MRI C/T spine with contrast first—rule out structural lesion given sensory level + sphincter loss.
2. Add serum vitamin E, thiamine, folate to malabsorption panel.
3. Check zinc concurrently; excess drives copper wasting.
4. MMA/homocysteine even if B12 “normal.”
5. Hold further IVIG; no demyelinating features confirmed.
6. Dental/nutritional hx + edentulous status heightens risk—quantify intake.
7. Neurology + nutrition co-manage; empiric copper repletion if levels delayed.

Expert:

Hello, Expert Clinician here.

Unifying Diagnosis: Copper deficiency myeloneuropathy (SCD-mimic) secondary to post-RYGB malabsorption.
Top Differentials:
1. Copper deficiency (best fit): RYGB, edentulous (poor intake), ascending myeloneuropathy with sensory level and sphincter loss—classic dorsal/lateral column pattern identical to SCD.
2. B12 deficiency/SCD: Same anatomy and risk profile; may coexist; must test regardless of "normal" B12 (MMA/homocysteine).
3. Compressive cervical myelopathy: Sensory level demands imaging exclusion, but 18-month symmetric ascent and malabsorption argue against purely structural cause.
4. CIDP (effectively excluded): Six months of IVIG without response plus cord signs (sensory level, sphincters) is incompatible—CIDP is peripheral only.
Key Pivot: The combination of IVIG non-response + thoracic sensory level + bowel/bladder involvement converts a "neuropathy" case into a myelopathy case, redirecting from immunotherapy to imaging and micronutrient evaluation.
Next Move: Contrast MRI cervical/thoracic spine first (exclude compression; seek dorsal column T2 signal), simultaneously drawing copper, ceruloplasmin, zinc, B12, MMA. Do not delay empiric repletion if labs lag.
Teaching Pearl: In post-bariatric "CIDP refractory to IVIG," think copper—B12 is checked reflexively; copper is checked deliberately, and excess zinc supplementation can itself induce deficiency.

Round 2

User:

Stage 2: Neurological Examination & Evoked Potentials (Timestamp: Admission / Day 1)
Physical & Neurological Exam: Alert, fully oriented, normal cranial nerves. Profound leg weakness (strength 0-1/5 in legs, 3/5 in hands/arms). Diffuse hyperreflexia (3+ biceps and patellar reflexes, 2+ ankles, absent plantar responses). Sensory level to pinprick at T4 with loss of vibration and proprioception in lower extremities. Stage 2 sacral pressure ulcer.
Electrophysiology & Somatosensory Evoked Potentials (SEP):
- Nerve Conduction Studies (NCS): Normal sensory Nerve Action Potentials (SNAPs) in lower extremities. Reduced motor response amplitudes in fibular and tibial nerves with normal conduction velocities.
- Needle EMG: Fibrillation potentials and positive sharp waves in distal muscles; reduced motor unit activation consistent with central upper motor neuron dysfunction.
- Tibial SEP: Absent P37 scalp waveform, confirming severe disruption of central dorsal column conduction.

Resident:

Hello, Chief Resident here.

Updated Key Findings:
Electrophysiology and clinical findings confirm a severe myeloneuropathy with central dorsal/lateral column disruption (T4 sensory level, upper motor neuron signs, absent Tibial P37 SEP) post-RYGB, definitively ruling out CIDP.

Differential Diagnoses:
1. Copper Deficiency Myelopathy (60%): Leading diagnosis given post-RYGB status, IVIG failure, and classic SCD-mimic dorsal column presentation.
2. Vitamin B12 Deficiency / Subacute Combined Degeneration (25%): High-prevalence post-bariatric complication with identical central cord pathways.
3. Compressive Cervical/Thoracic Myelopathy (10%): Sharp T4 sensory level requires structural exclusion.
4. Other/Combined Malabsorptive Deficiencies (5%): e.g., Vitamin E deficiency or complex micronutrient failure.

Prioritized Next Steps:
1. Urgent MRI Cervical and Thoracic Spine (with contrast): Rule out structural compression and look for dorsal column T2 hyperintensity (classic "inverted V" sign).
2. Comprehensive Serum Micronutrient Panel: Measure copper, ceruloplasmin, zinc, vitamin B12, methylmalonic acid (MMA), homocysteine, and vitamin E.
3. Empiric Repletion: Initiate immediate IV copper and IM vitamin B12 pending lab results to prevent irreversible neurological damage.
4. Supportive Care: Implement sacral pressure ulcer care and neurogenic bladder/bowel management.

Attending:

Hello Attending Consultant here

Critique: Correctly pivots to myeloneuropathy and de-emphasizes CIDP. Imaging still correctly prioritized, but empiric dual repletion (Cu + B12) is appropriate; vitamin E addition remains incomplete. Pressure-ulcer and sphincter management under-addressed relative to acuity.

Top 3 DDx:
1. Copper-deficiency myeloneuropathy (post-RYGB)
2. B12 deficiency / SCD (coexistent or primary)
3. Structural compressive myelopathy (must exclude)

Specific points:
1. Stat contrast MRI C/T spine—seek inverted-V dorsal-column T2 hyperintensity; rule out cord compression given T4 level + sphincters.
2. Draw Cu, ceruloplasmin, Zn, B12, MMA, Hcy, vit E simultaneously.
3. Start IV copper + IM B12 immediately; do not await labs.
4. Quantify zinc intake/supplements (iatrogenic Cu wasting).
5. Wound care + urodynamics for stage-2 ulcer and neurogenic bladder.
6. Hold all immunotherapy; NCS/SEP exclude demyelinating polyneuropathy.
7. Nutrition/bariatric surgery consult for long-term repletion strategy.

Expert:

Hello, Expert Clinician here.

Unifying Diagnosis: Copper-deficiency myeloneuropathy (SCD-mimic) post-RYGB—now electrophysiologically confirmed as central (absent P37, UMN signs, T4 level) with superimposed axonal motor neuropathy (low CMAPs, fibrillations, preserved SNAPs). This is precisely the copper phenotype; CIDP is definitively excluded.
Top Differentials:
1. Copper deficiency (strongest fit): Axonal motor + dorsal column + RYGB + IVIG failure.
2. B12 deficiency: Identical tract pattern; frequently coexists—treat both empirically.
3. Compressive myelopathy: Mandatory to image; absent plantar responses do not exclude it.
Key Pivot: NCS showing reduced CMAPs with normal velocities and preserved SNAPs—an axonal motor neuronopathy, not demyelination—is the signature of copper deficiency, formally closing the CIDP diagnosis.
Next Move: Draw Cu/Zn/ceruloplasmin/B12/MMA now, then MRI C/T spine, then infuse copper immediately—hematologic recovery is prompt; neurological recovery is slow and incomplete, so delay is costly.
Teaching Pearl: Preserved sensory responses with lost motor amplitudes and fibrillations = "motor axonal + dorsal column" pattern—think copper before you think plasma exchange.

Round 3

User:

Stage 3: Spine MRI, CSF Diagnostics & Initial Laboratory Panel (Timestamp: Hospital Days 1-3)
Diagnostic Workup:
- Spine MRI (Cervical, Thoracic, Lumbar with Contrast): Normal cord caliber without parenchymal signal abnormality, cord compression, nerve root enhancement, or demyelinating lesions. Mild degenerative changes only.
- Lumbar Puncture / CSF Analysis: Colorless, clear, glucose 47 mg/dL, protein 45 mg/dL (normal), WBC count 7-15 cells/µL (96% neutrophils, sterile cultures).
- Initial Laboratory Evaluation:
- Hemogram & Protein: Mild leukopenia (WBC 1.8–3.9 x 10³/µL), normocytic anemia (Hb 9.9–10.4 g/dL), normal platelets (293,000/µL). Serum IgG 2780 mg/dL (polyclonal hypergammaglobulinemia), ANA positive 1:40 (speckled).
- Vitamin Panel: Normal Vitamin B12 (378 pg/mL with normal Methylmalonic Acid 0.22 nmol/mL), normal Folate, normal B6, normal Vitamin E, normal Vitamin D. Negative HIV, HTLV-1/2, Lyme, Syphilis serologies.

Resident:

Hello, Chief Resident here.

Updated Key Findings:
MRI excludes structural compression and demyelination. Normal B12/MMA definitively rules out B12 deficiency. Crucially, new leukopenia and normocytic anemia combined with post-RYGB status and non-compressive myeloneuropathy strongly point to severe copper depletion.

Differential Diagnoses:
1. Primary Malabsorptive Copper Deficiency Myeloneuropathy (85%): Classic post-RYGB presentation combining progressive tractopathy, normal B12/MMA, and hematologic cytopenias (anemia + leukopenia).
2. Zinc Excess-Induced Copper Deficiency (10%): Secondary copper depletion driven by excess zinc (e.g., denture fixatives in an edentulous patient or OTC supplements).
3. Seronegative Autoimmune/Inflammatory Myelopathy (5%): Low probability; hypergammaglobulinemia and mild CSF pleocytosis are likely reactive, and normal MRI argues against primary neuroinflammation.

Prioritized Next Steps:
1. Serum Copper, Ceruloplasmin, and Serum/24-hour Urine Zinc levels (Urgent confirmation).
2. Immediate Empiric IV Copper Repletion (e.g., copper gluconate 2–4 mg IV daily; do not await lab results).
3. Screening for Hidden Zinc Exposure: Audit denture adhesive use and dietary supplements.
4. Bone Marrow Aspirate/Biopsy: If cytopenias do not improve, evaluate for vacuolated erythroid/myeloid precursors and ringed sideroblasts.

Attending:

Hello Attending Consultant here

Critique: Excellent exclusion of structural/B12 etiologies; correctly elevates copper deficiency with cytopenias as pathognomonic. Overweights primary vs zinc-induced split; bone-marrow biopsy premature before levels/repletion. Mild CSF neutrophilia/ANA are distractors—do not pursue autoimmune workup yet.

Top 3 DDx:
1. Copper-deficiency myeloneuropathy (post-RYGB malabsorption)
2. Zinc-induced copper deficiency (denture cream/supplements)
3. Combined micronutrient myeloneuropathy (residual risk)

Specific points:
1. Stat serum Cu, ceruloplasmin, Zn (serum + 24h urine).
2. Empiric IV copper gluconate 2–4 mg/day now—do not await labs.
3. Explicitly audit denture adhesives (zinc oxide) given edentulous state.
4. Serial CBC to track hematologic recovery as Cu repletion marker.
5. Defer marrow biopsy unless cytopenias persist >2 weeks post-repletion.
6. Nutrition consult for lifelong Cu/Zn monitoring post-RYGB.
7. Ignore low-titer ANA/polyclonal IgG; no further serologies indicated.

Expert:

Hello, Expert Clinician here.

Unifying Diagnosis: Copper-deficiency myeloneuropathy with hematologic confirmation (leukopenia + normocytic anemia)—the cytopenias are the biochemical footprint of copper depletion, now nearly conclusive post-RYGB with normal B12/MMA.
Top Differentials:
1. Primary malabsorptive copper deficiency (fits perfectly): Neurologic + hematologic tandem is diagnostic-grade.
2. Zinc-induced copper deficiency: Edentulous patient—denture cream zinc must be interrogated; alters management (source removal).
3. Combined deficiency: Vitamins E/B6/folate normal; largely excluded.
Key Pivot: The myeloneuropathy–cytopenia dyad in a bariatric patient with excluded B12. Hematologic involvement distinguishes copper deficiency from other tractopathies and predicts hematologic (not neurologic) reversibility.
Next Move: Copper/ceruloplasmin/zinc levels drawn, then IV copper started without waiting—oral absorption is unreliable post-RYGB. Question denture adhesives specifically.
Teaching Pearl: Copper deficiency is the "great hematologic-neurologic impostor"—unexplained anemia-leukopenia plus a dorsal column syndrome after gastric bypass is the diagnosis; marrow mimics MDS, so check copper before the biopsy needle.

Round 4

User:

Stage 4: Trace Element & Targeted Micronutrient Assay (Timestamp: Hospital Days 3-5)
Targeted Evaluation & Re-History:
- Denture Cream & Nutritional Re-History: Patient reports edentulism following weight loss and admits to using half a tube of zinc-containing denture adhesive cream daily for ill-fitting dentures.
- Targeted Micronutrient Panel:
- Total Serum Copper: 0.12 µg/mL (1.89 µmol/L; severe hypocupremia, reference 0.75–1.45 µg/mL).
- Serum Ceruloplasmin: 9 mg/dL (profoundly decreased, reference 20–60 mg/dL).
- Serum Zinc: 1.32 µg/mL (20.19 µmol/L; significantly elevated, reference 0.66–1.10 µg/mL).
- Pathology Unifying Diagnosis: Copper Deficiency Myelopathy (and Myeloneuropathy) induced by Roux-en-Y gastric bypass malabsorption and competitive zinc toxicity from excessive denture adhesive use.

Resident:

Hello, Chief Resident here.

Updated Key Findings:
Definitive laboratory and history confirmation: severe hypocupremia (0.12 µg/mL), low ceruloplasmin (9 mg/dL), and hyperzincemia (1.32 µg/mL) secondary to heavy use of zinc-containing denture cream (half tube/day) on a background of RYGB malabsorption.

Differential Diagnoses:
1. Zinc-Induced Copper Deficiency Myeloneuropathy (95%): Excess zinc upregulates intestinal enterocyte metallothionein, which preferentially binds and traps copper, causing severe copper depletion and subsequent myeloneuropathy and cytopenias.
2. Primary Malabsorptive Copper Deficiency (5%): Pure post-bariatric malabsorption, though less likely given clear hyperzincemia and massive zinc exposure.

Management Plan & Next Steps:
1. Source Control: Discontinue all zinc-containing denture creams and oral zinc supplements immediately.
2. Acute Repletion: Administer IV copper gluconate (2 mg/day for 5–7 days), then transition to oral copper (2–4 mg elemental copper daily).
3. Monitoring: Track weekly CBC, copper, ceruloplasmin, and zinc levels. Cytopenias typically resolve within weeks; neurological recovery is slower and may remain incomplete.
4. Rehabilitation & Dental Care: Dental consult for ill-fitting dentures; intensive inpatient neuro-rehabilitation, bladder training, and sacral ulcer care.

Attending:

Hello Attending Consultant here

Critique: Accurate unification and source control; dosing transition and monitoring timelines under-specified. Rehab prioritized correctly, but long-term absorption strategy post-RYGB incomplete. No need for further differentials beyond confirmation.

Top 3 DDx:
1. Zinc-induced copper-deficiency myeloneuropathy (denture cream + RYGB)
2. Primary post-RYGB copper malabsorption (minor contributor)
3. Residual mixed micronutrient deficit (excluded by labs)

Specific points:
1. Stop all Zn adhesives/supplements immediately; switch to Zn-free denture fixative.
2. IV Cu gluconate 2–4 mg/day ×5–7 d, then oral Cu 4–8 mg/day lifelong.
3. Serial Cu/ceruloplasmin/Zn + CBC q1–2 wk until normalized.
4. Expect rapid hematologic recovery; neurologic plateau likely incomplete.
5. Dental consult for implant/refit to eliminate adhesive need.
6. Lifelong post-bariatric micronutrient surveillance (Cu/Zn/B12).
7. Multidisciplinary rehab + wound/bladder protocols.

Expert:

Hello, Expert Clinician here.

Unifying Diagnosis: Zinc-induced copper-deficiency myeloneuropathy—denture adhesive zinc superimposed on RYGB malabsorption. The triad of severe hypocupremia, low ceruloplasmin, and hyperzincemia is pathognomonic; zinc-driven metallothionein traps intestinal copper, completing the depletion.
Top Differentials:
1. Zinc-induced copper deficiency (confirmed): Explains everything—myeloneuropathy, cytopenias, hyperzincemia.
2. Primary bariatric malabsorption: Contributory substrate; the zinc load was the accelerant.
3. All others excluded by normal B12/MMA/E and MRI.
Key Pivot: The re-history—half a tube of zinc denture cream daily. Without targeted questioning, this iatrogenic exposure remains invisible; the labs merely confirm what the bedside history revealed.
Next Move: Remove the zinc source, IV copper then high-dose oral maintenance (RYGB compromises absorption), and serial copper/zinc/CBC surveillance. Expect hematologic recovery in weeks; anticipate partial, plateaued neurologic recovery over months—counsel the patient honestly.
Teaching Pearl: Ask about denture cream. Excess zinc is a cause of copper deficiency, and half a tube daily can deliver tens of milligrams of zinc—history is the cheapest, most powerful assay in trace-metal disease.

Round 5

User:

Stage 5: High-Dose Parenteral Copper Repletion & Neurological Recovery (Timestamp: Follow-up & Discharge)
Management & Outcome:
- Targeted Management Plan:
- Complete cessation of zinc-containing denture adhesive.
- Intravenous Copper Chloride (2 mg IV daily x 5 days) followed by high-dose oral Copper supplementation (8 mg daily tapered to 2 mg maintenance).
- Pain management with Pregabalin for neuropathic pain.
- Clinical Outcome:
- Complete normalization of serum copper and ceruloplasmin levels.
- At 6-month follow-up: Substantial recovery of proximal arm and leg strength; patient transitioned from wheelchair to walking with a walker, with partial persistent distal stocking-glove numbness.

Resident:

Hello, Chief Resident here.

Updated Key Findings:
Discontinuation of zinc-containing denture cream paired with IV and oral copper repletion resulted in biochemical normalization (serum copper and ceruloplasmin) and major functional recovery at 6 months (progressing from wheelchair dependence to ambulating with a walker). Residual distal sensory deficits persist, reflecting irreversible prior axonal damage.

Definitive Diagnosis:
1. Zinc-Induced Copper Deficiency Myeloneuropathy (100%): Fully confirmed by severe initial hypocupremia/hyperzincemia, documented excessive zinc denture adhesive exposure on a post-RYGB background, and successful biochemical/neurological recovery following copper replacement and zinc elimination.

Long-Term Management Plan:
1. Maintenance & Prevention: Continue oral copper maintenance (2 mg daily) indefinitely; ensure complete avoidance of zinc-containing denture adhesives or supplements.
2. Surveillance: Monitor serum copper, zinc, ceruloplasmin, and complete blood counts every 6–12 months to prevent recurrence.
3. Dental Care: Coordinate with prosthodontics for proper-fitting, zinc-free dentures or dental implants.
4. Rehabilitation: Continue physical therapy for gait training and maintain pregabalin for residual distal neuropathic symptoms.

Attending:

Hello Attending Consultant here

Critique: Plan correctly locks in source removal + repletion with documented recovery; however, taper schedule lacks precision, surveillance interval too lax initially, and no explicit counseling on incomplete neurologic recovery or RYGB-specific absorption limits. Pregabalin appropriate but adjunct PT intensity under-emphasized.

Top 3 DDx:
1. Zinc-induced copper-deficiency myeloneuropathy (confirmed)
2. Residual post-RYGB pure copper malabsorption
3. Fixed axonal sequelae (non-reversible component)

Specific points:
1. Confirm Zn-free adhesive or implants; zero tolerance for occult Zn.
2. Maintain oral Cu 2–4 mg/day lifelong; recheck levels q3 mo ×1 yr then q6–12 mo.
3. Serial CBC + Cu/ceruloplasmin/Zn to catch early recurrence.
4. Counsel: hematologic cure expected; distal sensory/motor deficits often plateau.
5. Intensify outpatient neuro-rehab + gait training for walker-to-cane progression.
6. Annual bariatric nutrition panel (Cu/Zn/B12/vit E).
7. Document functional gains; avoid further immunotherapy.

Expert:

Hello, Expert Clinician here.

Unifying Diagnosis: Zinc-induced copper-deficiency myeloneuropathy—diagnosis proven by therapeutic trial: zinc removal plus copper repletion normalized biochemistry and reversed the wheelchair state to ambulation.
Top Differentials: Now closed. Residual stocking-glove numbness reflects fixed axonal loss, not ongoing disease—distinguish sequelae from recurrence.
Key Pivot of the Entire Case: The re-history about denture cream. A "refractory CIDP" was actually a reversible, iatrogenic-toxic-metabolic myeloneuropathy—three failed interventions (laminectomy, IVIG, misdiagnosis) preceded one simple question.
Next Move: Lifelong maintenance copper with structured surveillance (Cu/Zn/ceruloplasmin/CBC quarterly ×1 year, then annually), prosthodontic refit to permanently eliminate adhesive zinc, and continued neuro-rehabilitation. Honest counseling: hematologic and proximal strength recovery is gratifying; distal sensory deficits are the permanent tax of 18 months' delay.
Teaching Pearls:
1. Bariatric patients need lifelong copper surveillance—not just B12.
2. Zinc excess causes copper deficiency; the two are reciprocals.
3. In "treatment-refractory" neuropathy, re-take the history before re-ordering the immunotherapy—diagnosis beat therapy here.

Top 15 Takeaways for Clinicians

  1. Clinical Spectrum of Copper Deficiency Myelopathy: Hypocupremia causes a progressive myeloneuropathy affecting the posterior and lateral columns of the spinal cord, clinically presenting identically to subacute combined degeneration (SCD).
  2. Dorsal Column vs Peripheral Neuropathy Localization: The combination of hyperreflexia (3+ reflexes), a sensory level to pinprick (T4 level), and bowel/bladder incontinence indicates central spinal cord dysfunction (myelopathy) rather than peripheral polyneuropathy like CIDP.
  3. Pitfall of Refractory CIDP Misdiagnosis: Progression of weakness and sensory loss despite months of Intravenous Immunoglobulin (IVIG) therapy should prompt immediate re-evaluation of central myelopathic and metabolic etiologies.
  4. Electrophysiological Signature: Nerve conduction studies showing preserved sensory nerve action potentials (SNAPs) alongside reduced motor response amplitudes (CMAPs) and absent P37 scalp waveforms on tibial somatosensory evoked potentials (SEP) confirm central dorsal column impairment with motor axonal involvement.
  5. Impact of Bariatric Malabsorption: Roux-en-Y gastric bypass (RYGB) bypasses the principal sites of dietary copper absorption in the duodenum and proximal jejunum, creating a permanent malabsorptive state.
  6. Iatrogenic Zinc Toxicity from Denture Cream: Excessive daily ingestion of zinc-containing denture adhesive (e.g., half a tube per day) provides massive oral zinc loads that induce intestinal enterocyte metallothionein.
  7. Mechanism of Metallothionein Copper Trapping: Metallothionein binds copper with higher affinity than zinc, trapping dietary copper within enterocytes that are subsequently sloughed into the GI tract, producing severe secondary hypocupremia.
  8. Hematologic Footprint of Hypocupremia: Copper is an essential cofactor for ceruloplasmin and hephaestin in iron transport and hematopoiesis; hypocupremia frequently presents with unexplained mild leukopenia, neutropenia, and normocytic or macrocytic anemia.
  9. Interpretation of Normal Vitamin B12: A normal serum B12 level and normal methylmalonic acid (MMA) do not rule out metabolic myelopathy; copper deficiency must be deliberately ordered as an independent micronutrient assay.
  10. Serum Ceruloplasmin as a Copper Marker: Because ceruloplasmin synthesis relies on copper incorporation, serum ceruloplasmin levels drop drastically (e.g., <10 mg/dL) alongside total serum copper in severe deficiency states.
  11. Primacy of Immediate Source Control: Treatment mandates immediate, permanent cessation of all zinc-containing denture adhesives, zinc supplements, and secondary zinc sources.
  12. Targeted Parenteral & Oral Copper Replacement: Initial treatment requires intravenous copper (e.g., copper chloride 2 mg IV daily for 5–7 days) to bypass intestinal malabsorption, followed by high-dose oral copper supplementation.
  13. Rapid Hematologic vs Slow Neurologic Recovery: Hematologic abnormalities (anemia and leukopenia) resolve within weeks of copper repletion, whereas neurological recovery is slow, partial, and dependent on early intervention before irreversible axonal loss occurs.
  14. Importance of Bedside Targeted Re-History: In patients with ill-fitting dentures and weight loss post-bariatric surgery, explicit questioning regarding denture cream brand and volume is the single highest-yield diagnostic maneuver.
  15. Long-Term Micronutrient Surveillance: Post-bariatric patients require lifelong periodic screening of copper, zinc, ceruloplasmin, B12, and complete blood counts to detect subclinical micronutrient depletion before permanent neurological deficits develop.